Quick Answer
BioRestorative Therapies, Inc. reported Total Assets of $4.08 million for the year ending 2025.
- BioRestorative Therapies, Inc. showed a decrease of -66.8% in Total Assets from 2024 to 2025.
- This data is from BioRestorative Therapies, Inc.'s annual report (Form 10-K), filed with the SEC on March 26, 2026.
- XBRL data for this metric is available from 2010 to 2025 (16 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Quarterly values from 10-Q filings: Q1 2012: $88.1 thousand | Q2 2012: $1.34 million | Q3 2012: $1.40 million | Q1 2013: $1.78 million | Q2 2013: $1.25 million | Q3 2013: $1.22 million | Q1 2014: $1.25 million | Q2 2014: $1.19 million | Q3 2014: $1.60 million | Q1 2015: $1.86 million | Q2 2015: $2.07 million | Q3 2015: $2.15 million | Q1 2016: $2.05 million | Q2 2016: $2.20 million | Q3 2016: $1.62 million | Q1 2017: $1.48 million | Q2 2017: $1.42 million | Q3 2017: $1.42 million | Q1 2018: $1.22 million | Q2 2018: $1.21 million | Q3 2018: $1.25 million | Q1 2019: $1.58 million | Q2 2019: $2.43 million | Q3 2019: $1.46 million | Q1 2020: $1.38 million | Q2 2020: $1.61 million | Q3 2020: $1.43 million | Q1 2021: $3.70 million | Q2 2021: $2.88 million | Q3 2021: $2.18 million | Q1 2022: $20.92 million | Q2 2022: $19.44 million | Q3 2022: $17.92 million | Q1 2023: $14.08 million | Q2 2023: $13.30 million | Q3 2023: $13.80 million | Q1 2024: $17.95 million | Q2 2024: $16.12 million | Q3 2024: $14.57 million | Q1 2025: $10.33 million | Q2 2025: $8.52 million | Q3 2025: $5.64 million.
- Over the full 16 years of available data (2010 to 2025), BioRestorative Therapies, Inc.'s Total Assets has grown by 770.8%.
- Historical annual values: Fiscal year 2025: $4.08 million | Fiscal year 2024: $12.28 million | Fiscal year 2023: $12.61 million | Fiscal year 2022: $16.43 million | Fiscal year 2021: $22.45 million | Fiscal year 2020: $4.35 million | Fiscal year 2019: $1.47 million | Fiscal year 2018: $1.19 million | Fiscal year 2017: $1.76 million | Fiscal year 2016: $1.58 million | Fiscal year 2015: $2.02 million | Fiscal year 2014: $1.69 million | Fiscal year 2013: $1.38 million | Fiscal year 2012: $1.27 million | Fiscal year 2011: $221.0 thousand | Fiscal year 2010: $468.5 thousand.
- Data sourced from SEC EDGAR public filings as of August 6, 2026.
Last verified: